Award notice Supplies

Suministro de Medicamentos exclusivos Selumetinib 10 mg cápsula (KOSELUGO 10 mg CAPSULAS DURAS) y Selumetinib 25 mg cápsula (KOSELUGO 25 mg CAPSULAS DURAS)

Notice published in Spanish. The AI analysis summarises it for you in your language.

Official notice and documents

Public buyer: Hospital Infantil Universitario Niño Jesús
Madrid
Place of performance: Madrid
Estimated value: €4,673,056 excl. VAT
Amount awarded: €2,209,081 excl. VAT
Bids received: 1
Procedure: Negotiated procedure without prior publication
The buyer consulted a few companies directly: it is no longer possible to take part.
Publication: 21 July 2026
Notice language: Spanish

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

Suministro de Medicamentos exclusivos Selumetinib 10 mg cápsula (KOSELUGO 10 mg CAPSULAS DURAS) y Selumetinib 25 mg cápsula (KOSELUGO 25 mg CAPSULAS DURAS)

Awarded to

ALEXION PHARMA SPAIN, S.L

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33600000

Winning prices for comparable contracts

A quarter below: €350,000
Median: €846,164
A quarter above: €2,267,877

Amounts awarded (excl. VAT) over the last 3 years for 265 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.

Similar contracts already awarded

Contract	Winner	Amount
Suministro de medicamento exclusivo Ravulizumab Hospital Infantil Universitario Niño Jesús · 16 September 2026	ALEXION PHARMA SPAIN, S.L.	€157,771
Suministro de Medicamentos de distribución exclusiva del laboratorio BIOMARIN PHARMACEUT ESPAÑA S.L. Hospital Infantil Universitario Niño Jesús · 2 September 2026	BIOMARIN PHARMACEUTICALS ESPAÑA S.L.	€77,601,945
Suministro de Medicamento exclusivo Setmelanotida 10mg/ml inyectable 1 ml (IMCIVREE 10MG/ML SOLUCIÓN INYECTABLE) Hospital Infantil Universitario Niño Jesús · 31 August 2026	EUROMED PHARMA SPAIN S.L.	€424,819
Suministro de Tafasitamab (DOE) OSAKIDETZA - Servicio Vasco de Salud - Organización Central · 23 October 2026	INCYTE BIOSCIENCES IBERIA, S.L.	€2,170,000
Suministro de IODIXANOL (VISIPAQUE) E IOHEXOL (OMNIPAQUE) de distribución exclusiva con destino al Servicio de Farmacia del Hospital Clínico San Carlos HOSPITAL CLINICO SAN CARLOS · 23 October 2026	GE HEALTHCARE BIO-SCIENCES, SAU	€505,350

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 504230-2026.